Description
Cathflo (alteplase) is a heart and blood pressure medications agent listed in our Heart and blood pressure medications directory and prescribed for heart failure and prevention or treatment of specified blood clots (1.1) (2.1). Administered via the intracatheter instillation into occluded central venous catheters route, Cathflo is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Cathflo is a medication containing the active pharmaceutical ingredient alteplase, classified pharmacologically as a heart and blood pressure medications agent (2.1). It is clinically indicated for the management of heart failure and prevention or treatment of specified blood clots as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Heart and blood pressure medications section of our catalogue, patients and prescribers frequently review Cathflo alongside related therapies such as Apixaban, Crestor (Rosuvastatin Calcium), Eliquis (Apixaban), and Lipitor (Atorvastatin).
Official Indications and Usage
Activase is a tissue plasminogen activator (tPA) indicated for the treatment of: Acute Ischemic Stroke (ais). Acute Myocardial Infarction (ami) to reduce mortality and incidence of heart failure.
Limitations of use: In ami: the risk of stroke may be greater than the benefit in patients at low risk of death from cardiac causes. Acute Massive Pulmonary Embolism (PE) for lysis. (1.1)
Mechanism of Action and Pharmacology
Alteplase is a serine protease responsible for fibrin-enhanced conversion of plasminogen to plasmin. It produces limited conversion of plasminogen in the absence of fibrin. When introduced into the systemic circulation at pharmacologic concentration, alteplase binds to fibrin in a thrombus and converts the entrapped plasminogen to plasmin. This initiates local fibrinolysis with limited systemic proteolysis. (1.1)
What is Heart failure?
Heart failure means the heart does not fill or pump as effectively as the body needs. Symptoms and treatment differ by the underlying heart problem. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Heart failure condition guide for appointment questions and related therapies (2.1).
What are Blood clots?
Blood clots can form in veins or arteries and obstruct blood flow. Prevention and treatment depend on where a clot forms and the person's risks. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Blood clots condition guide for appointment questions and related therapies (2.1).
Ordering Cathflo from Canada for U.S. Delivery
U.S. patients can order Cathflo (Alteplase) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Cathflo |
| Chemical / Generic Name | Alteplase |
| Pharmacological Class | Heart and blood pressure medications agent |
| Therapeutic Category | Heart and blood pressure medications |
| Elimination Half-Life | ~5 minutes (1.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Intracatheter Instillation |
| Dosage Forms & Strengths | 50 mg lyophilized powder in single-dose vial with 50 mL swfi USP for reconstitution 100 mg lyophilized powder in single-dose vial with 100 mL swfi USP for |
| Primary Indications | Heart Failure And Prevention Or Treatment Of Specified Blood Clots |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| NLM RxNorm Concept ID (RxCUI) | 1804799, 1804802, 1804804, 1804806 |
| FDA Application License | BLA103172 |
| Official DailyMed SetID | c669f77c-fa48-478b-a14b-80b20a0139c2 |
| Catalogue Index Links | Letter C Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
Acute Ischemic Stroke: The recommended dose is 0.9 mg/kg (not to exceed 90 mg total dose) infused intravenously over 60 minutes with 10% of the total dose administered as an initial bolus over 1 minute. Acute Myocardial Infarction: The recommended total dose is based on patient weight, not to exceed 100 mg. Acute Massive Pulmonary Embolism: The recommended dose is 100 mg administered by IV infusion over 2 hours. Do not add other medications to infusions containing Activase. (1.1)
Presentations and Strengths
50 mg lyophilized powder in single-dose vial with 50 mL swfi USP for reconstitution 100 mg lyophilized powder in single-dose vial with 100 mL swfi USP for reconstitution 50 mg and 100 mg lyophilized powder in single-dose vials with Sterile Water for Injection USP for reconstitution. (1.1)
Administration Guidance
Cathflo is administered by catheter instillation under the supervision of a qualified healthcare professional according to the official clinical protocol (1.1).
Missed Dose Guidance
If you miss a scheduled dose of Cathflo, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Cathflo is alteplase (2.1).
Excipients and Formulation Carriers
Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).
Cautions and important safety information
Contraindications
General Active internal bleeding. Recent intracranial or intraspinal surgery or serious head trauma. Intracranial conditions that may increase the risk of bleeding. Bleeding diathesis. Current severe uncontrolled hypertension. (1.1)
Key Clinical Precautions
Before starting or continuing Cathflo, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Cardiovascular events: Depending on the medication class and underlying medical history, patients should be monitored for signs of cardiovascular events such as chest pain, shortness of breath, sudden weakness, or slurred speech.
- Gastrointestinal ulceration, bleeding, and perforation: Serious gastrointestinal adverse events including inflammation, bleeding, ulceration, and perforation of the esophagus, stomach, or intestines can occur with or without warning symptoms.
- Acute pancreatitis: Persistent, severe abdominal pain, sometimes radiating to the back and accompanied by vomiting, can indicate acute pancreatitis. Discontinue therapy and contact your clinician promptly if these symptoms develop.
- Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
- Angioedema: Swelling of the face, extremities, lips, tongue, glottis, or larynx can occur at any time during treatment. Airway-involving angioedema requires emergency medical intervention.
- Hemorrhage and bleeding risk: Anticoagulant, antiplatelet, or gastrointestinal-affecting therapies can increase the risk of serious or fatal bleeding. Report unusual bruising, nosebleeds, blood in urine or stools, black tarry stools, or coughing up blood immediately.
Pregnancy, Lactation, and Special Populations
Published studies and case reports on alteplase use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. Alteplase is embryocidal in rabbits when intravenously administered during organogenesis at the clinical exposure for ami, but no maternal or fetal toxicity was evident at lower exposure in pregnant rats or rabbits. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. The estimated background risk of major birth defects and miscarriage for the indicated populations is unknown. (1.1)
Interactions
Official Drug Interaction Overview
The interaction of Activase with other cardioactive or cerebroactive drugs has not been studied. Anticoagulants and antiplatelet drugs increase the risk of bleeding if administered prior to, during, or after Activase therapy. In the post-marketing setting, there have been reports of angioedema in patients (primarily patients with ais) receiving concomitant angiotensin-converting enzyme inhibitors. Anticoagulants and drugs that inhibit platelet function increase the risk of bleeding when administered with Activase therapy. Concomitant angiotensin-converting enzyme inhibitors may increase the risk of angioedema. (1.1)
Important Interaction Categories
Concomitant use of Cathflo with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Anticoagulants (such as Eliquis (Apixaban), Xarelto (Rivaroxaban), or Pradaxa (Dabigatran) in our Blood health directory): Combining multiple anticoagulants or agents that affect coagulation markedly increases the risk of major bleeding.
- Antiplatelet agents (such as aspirin, Plavix (Clopidogrel), Prasugrel, or Brilinta (Ticagrelor)): Co-administration increases the risk of bleeding events; only combine under explicit direction from your cardiovascular or prescribing specialist.
Side effects
Like all medications, Cathflo can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; eating smaller, lower-fat meals and avoiding lying down immediately after eating may help reduce nausea.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Peripheral edema (swelling of ankles, feet, or hands): Fluid retention may occur; notify your doctor if swelling is rapid or accompanied by shortness of breath.
Clinical Trial and Postmarketing Adverse Reactions
The following adverse reactions are discussed in greater detail in the other sections of the label: Bleeding Hypersensitivity Thromboembolism Cholesterol Embolization The most frequently occurring adverse reaction ( > 5%) is bleeding. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. The most frequent adverse reaction associated with Activase in all approved indications is bleeding. (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Store lyophilized Activase at controlled room temperature not to exceed 30°C (86°F), or under refrigeration at 2° to 8°C (36° to 46°F). Protect the lyophilized material during extended storage from excessive exposure to light. If stored between 2-30°C (36-86°F), Activase may be used within 8 hours following reconstitution. Discard any unused solution after administration is complete. Do not use beyond the expiration date stamped on the vial. (1.1)
Store Cathflo in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
Frequently Asked Questions About Cathflo
What is Cathflo and what active ingredient does it contain?
Cathflo is a heart and blood pressure medications agent containing the active pharmaceutical ingredient alteplase. It is supplied for intracatheter instillation into occluded central venous catheters administration and requires a valid prescription where applicable.
How does Cathflo work in the body?
Alteplase is a serine protease responsible for fibrin-enhanced conversion of plasminogen to plasmin. It produces limited conversion of plasminogen in the absence of fibrin. When introduced into the systemic circulation at pharmacologic concentration, alteplase binds to fibrin in a thrombus and converts the entrapped plasminogen to plasmin.
What conditions is Cathflo prescribed to treat?
Cathflo is primarily indicated for heart failure and prevention or treatment of specified blood clots. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Cathflo?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Cathflo is administered via the intracatheter instillation into occluded central venous catheters route. Use it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Cathflo?
Commonly reported side effects of Cathflo include feeling sick, vomiting, and swelling. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Cathflo?
Important interaction categories for Cathflo include anticoagulants and antiplatelet medicines. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Cathflo be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Cathflo to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Cathflo online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Cathflo (Alteplase) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Cathflo have a generic equivalent (Alteplase) at a Canada pharmacy?
Currently, Cathflo (Alteplase) is dispensed in our catalogue as a brand-name formulation. Check our Alteplase active ingredient hub for updates as licensed generic presentations become available.
How is Cathflo shipped to U.S. residents, and how much does shipping cost?
Cathflo ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Cathflo prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Cathflo prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Cathflo (Alteplase) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Activase. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: Heart Failure. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (3.1) MedlinePlus Medical Encyclopedia: Blood Clots. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (4.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
